1 1818 144 PROSPECTIVE RANDOMIZED TRIAL OF STANDARD ANTIEMETIC THERAPY WITH YOGA VERSUS STANDARD ANTIEMETIC THERAPY ALONE FOR HIGHLY EMETOGENIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN SOUTH ASIAN POPULATION. AIM/BACKGROUND: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IS ONE OF THE MOST DISTRESSING SIDE EFFECTS OF HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS. THERE HAVE BEEN CONTINUOUS EFFORTS IN THE DIRECTION TO CONTROL CINV BY MANY INVESTIGATORS. MATERIALS AND METHODS: RANDOMLY SELECTED PATIENTS WERE THOSE RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN GROUPED INTO YOGA AND STANDARD ANTIEMETIC THERAPY (N = 50) JUST BEFORE RECEIVING CHEMOTHERAPY AND CONTINUED FOR THE FOLLOWING DAYS AND OTHER GROUP (N = 50) RECEIVED ONLY THE STANDARD ANTIEMETIC AGENT. BOTH THE GROUPS WERE ASSESSED, FOLLOWED FOR ACUTE AND DELAYED ONSET OF CHEMOTHERAPY-INDUCED AND ANTICIPATORY NAUSEA AND VOMITING USING RADIATION THERAPY ONCOLOGY GROUP GRADING FOR THE SAME. WE ALSO ASSESSED THE QUALITY OF LIFE OF THE PATIENT USING THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL QUESTIONNAIRE. RESULTS: THE MEDIAN AGE GROUP OF THE PATIENTS WAS 51 YEARS WITH MALE:FEMALE RATIO 2:1, THE EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) PERFORMANCE STATUS WAS 0/1 IN 38% OF THE SELECTED POPULATION, WHILE ECOG 2 IN 62% OF THE PATIENTS. IN YOGA ARM, INSIGNIFICANT REDUCTION IN CHEMOTHERAPY-INDUCED NAUSEA (90% VS. 78%, P = 0.35) AND BUT SIGNIFICANT REDUCTION IN VOMITING (42% VS. 22%, P =0.01) WAS OBSERVED AS COMPARED TO THE STANDARD ANTIEMETICS ONLY ARM. THERE WAS A SIGNIFICANT REDUCTION IN GRADE 2 AND 3 NAUSEA (84% VS. 38% P < 0.01) AND VOMITING (14% VS. 0% P < 0.01). QUALITY OF LIFE IS ALSO SIGNIFICANTLY IMPROVED IN THE YOGA ARM, ESPECIALLY IN THE ECOG 2 PERFORMANCE STATUS. CONCLUSIONS: THIS STUDY CONCLUDES THAT YOGA ALONG WITH STANDARD ANTIEMETIC MEDICATION SHOULD BE A PART OF THE MANAGEMENT PLAN FOR THE CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY. 2019 2 97 27 A NONRANDOMIZED COMPARISON STUDY OF SELF-HYPNOSIS, YOGA, AND COGNITIVE-BEHAVIORAL THERAPY TO REDUCE EMOTIONAL DISTRESS IN BREAST CANCER PATIENTS. THE AUTHORS ASKED BREAST CANCER (BC) PATIENTS TO PARTICIPATE IN 1 OF 3 MIND-BODY INTERVENTIONS (COGNITIVE-BEHAVIORAL THERAPY (CBT), YOGA, OR SELF-HYPNOSIS) TO EXPLORE THEIR FEASIBILITY, EASE OF COMPLIANCE, AND IMPACT ON THE PARTICIPANTS' DISTRESS, QUALITY OF LIFE (QOL), SLEEP, AND MENTAL ADJUSTMENT. NINETY-NINE PATIENTS COMPLETED AN INTERVENTION (CBT: N = 10; YOGA: N = 21; AND SELF-HYPNOSIS: N = 68). RESULTS SHOWED HIGH FEASIBILITY AND HIGH COMPLIANCE. AFTER THE INTERVENTIONS, THERE WAS NO SIGNIFICANT EFFECT IN THE CBT GROUP BUT SIGNIFICANT POSITIVE EFFECTS ON DISTRESS IN THE YOGA AND SELF-HYPNOSIS GROUPS, AND, ALSO, ON QOL, SLEEP, AND MENTAL ADJUSTMENT IN THE SELF-HYPNOSIS GROUP. IN CONCLUSION, MIND-BODY INTERVENTIONS CAN DECREASE DISTRESS IN BC PATIENTS, BUT RCTS ARE NEEDED TO CONFIRM THESE FINDINGS. 2017 3 2653 46 YOGA IMPROVES OCCUPATIONAL PERFORMANCE, DEPRESSION, AND DAILY ACTIVITIES FOR PEOPLE WITH CHRONIC PAIN. BACKGROUND: CHRONIC PAIN IS A COMPLEX ACCUMULATION OF PHYSICAL, PSYCHOLOGICAL, AND SOCIAL CONDITIONS, THUS INTERVENTIONS THAT ADDRESS PAIN AND PROMOTE OCCUPATIONAL PERFORMANCE ARE NEEDED. A HOLISTIC INTERVENTION, WITH MIND AND BODY COMPONENTS, IS LIKELY NECESSARY TO BEST TREAT THE COMPLEXITIES OF CHRONIC PAIN. THUS, WE DEVELOPED AND TESTED A YOGA INTERVENTION FOR PEOPLE WITH CHRONIC PAIN. OBJECTIVES: IN A RANDOMIZED CONTROL TRIAL (RCT), PARTICIPANTS WITH CHRONIC PAIN WERE RANDOMIZED TO A YOGA INTERVENTION OR USUAL CARE GROUP. BETWEEN AND WITHIN GROUP DIFFERENCES FOR PRE-AND POST-OUTCOME MEASURE SCORES WERE ASSESSED FOR: OCCUPATIONAL PERFORMANCE, COMPLETION OF ACTIVITIES, AND DEPRESSION. METHODS: PILOT RCT WITH PARTICIPANT ALLOCATION TO 8 WEEKS OF YOGA OR USUAL CARE. BOTH GROUPS RECEIVED ONGOING MONTHLY SELF-MANAGEMENT PROGRAMMING. DATA WERE COLLECTED BEFORE AND AFTER THE 8-WEEK INTERVENTION. PARTICIPANTS WERE RANDOMIZED TO YOGA OR USUAL CARE AFTER BASELINE ASSESSMENTS. DEMOGRAPHICS WERE COLLECTED AND MEASURES INCLUDED: CANADIAN OCCUPATIONAL PERFORMANCE MEASURE (COPM) TO ASSESS OCCUPATIONAL PERFORMANCE; THE 15-ITEM FRENCHAY ACTIVITIES INDEX (FAI)(ACTIVITIES); AND THE 9-ITEM PATIENT HEALTH QUESTIONNAIRE (PHQ-9) FOR DEPRESSION. INDEPENDENT T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN GROUPS. PAIRED T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN PRE- AND POST 8-WEEK INTERVENTION FOR BOTH THE YOGA AND THE USUAL CARE GROUPS. PERCENT CHANGE SCORES AND EFFECT SIZES WERE CALCULATED. RESULTS: 83 PEOPLE WERE RECRUITED FOR THE STUDY AND COMPLETED BASELINE ASSESSMENTS; 44 INDIVIDUALS WERE RANDOMIZED TO YOGA AND 39 TO THE CONTROL GROUP. THE AVERAGE AGE OF ALL PARTICIPANTS WAS 51.4+/-10.5 YEARS, 68% WERE FEMALE; AND 60% HAD AT LEAST SOME COLLEGE EDUCATION. THERE WERE NO SIGNIFICANT DIFFERENCES IN DEMOGRAPHICS OR OUTCOME MEASURES BETWEEN GROUPS AT BASELINE OR 8 WEEKS; HOWEVER, THE STUDY WAS NOT POWERED TO SEE SUCH DIFFERENCES. INDIVIDUALS RANDOMIZED TO THE CONTROL GROUP DID NOT SIGNIFICANTLY IMPROVE IN ANY OUTCOME MEASURE OVER THE 8 WEEKS. THERE WERE SIGNIFICANT IMPROVEMENTS IN COPM PERFORMANCE AND COPM SATISFACTION SCORES FOR INDIVIDUALS RANDOMIZED TO THE YOGA GROUP; BOTH SCORES SIGNIFICANTLY IMPROVED. COPM PERFORMANCE IMPROVED BY 27% WITH A MODERATE TO LARGE EFFECT SIZE (3.66+/-1.85 VS 4.66+/-1.93, P < 0.001, D = 0.76). COPM SATISFACTION SIGNIFICANTLY IMPROVED BY 78% (2.14+/-2.31 VS. 3.80+/-2.50, P < 0.001) AND HAD A LARGE EFFECTS SIZE (D = 1.02). FAI SCORES IMPROVED, INDICATING INCREASED ACTIVITY OR ENGAGEMENT IN DAILY OCCUPATION DURING THE 8-WEEK INTERVENTION. SCORES INCREASED BY 5% (38.13+/-8.48 VS. 39.90+/-8.57, P = 0.024) WITH A SMALL EFFECT SIZE (D = 0.37). DEPRESSION SIGNIFICANTLY DECREASED FROM 13.21+/-5.60 TO 11.41+/-5.82, P = 0.041, WITH A SMALL EFFECT SIZE. CONCLUSION: DATA FROM THIS PILOT RCT INDICATE YOGA MAY BE AN EFFECTIVE THERAPEUTIC INTERVENTION WITH PEOPLE IN CHRONIC PAIN TO IMPROVE OCCUPATIONAL PERFORMANCE, INCREASE ENGAGEMENT IN ACTIVITIES, AND DECREASE DEPRESSION. OCCUPATIONAL THERAPY PRACTITIONERS MAY CONSIDER ADDING YOGA AS A TREATMENT INTERVENTION TO ADDRESS THE NEEDS OF PEOPLE WITH PAIN. 2019 4 1381 42 IMPACT OF NATUROPATHY, YOGA, AND DIETARY INTERVENTIONS AS ADJUVANT CHEMOTHERAPY IN THE MANAGEMENT OF STAGE II AND III ADENOCARCINOMA OF THE COLON. INTRODUCTION: NATUROPATHY, YOGA AND DIETARY INTERVENTIONS ARE KNOWN TO IMPROVE THE QUALITY OF LIFE IN CANCER PATIENTS. WE AIM TO EVALUATE THE EFFECT OF NATUROPATHY INTERVENTIONS ALONG WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WHO UNDERWENT SURGERY FOR ADENOCARCINOMA OF THE COLON. METHODS: A TOTAL OF 116 ADULT PATIENTS WERE RANDOMISED IN TO ONE OF THE TWO GROUPS; THE EXPERIMENTAL GROUP RECEIVED NATUROPATHY, YOGA AND DIETARY INTERVENTIONS AND THE CONTROL GROUP RECEIVED PSYCHO-SOCIAL COUNSELLING IN ADDITION TO STANDARD CHEMOTHERAPY. HAEMATOLOGICAL, BIOCHEMICAL AND PSYCHOLOGICAL EVALUATIONS WERE PERFORMED AT SET INTERVALS DURING A TOTAL PERIOD OF EIGHTEEN MONTHS STARTING FROM THE FIRST CYCLE OF ADJUVANT CHEMOTHERAPY. RESULTS: RESULTS SHOWED THAT THE OVERALL HEMOGLOBIN (P < 0.0001) AND CARCINOEMBRYONIC ANTIGEN (CEA) (P = 0.0038) LEVELS WERE STATISTICALLY SIGNIFICANT IN PATIENTS ON THE EXPERIMENTAL ARM. THE REST OF THE LABORATORY PARAMETERS, VIZ. TOTAL LEUKOCYTE COUNT, PLATELET COUNTS, AND SERUM CREATININE LEVELS, FOR OVERALL DATA WAS NOT STATISTICALLY SIGNIFICANT IN BOTH THE GROUPS. PSYCHOLOGICAL ATTRIBUTES SUCH AS ANXIETY, DEPRESSION, SYMPTOM SEVERITY, AND FUNCTIONAL LIVING INDEX: CANCER (FLIC) WERE FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.0001) IN THE EXPERIMENTAL SUBJECTS AS COMPARED WITH THOSE IN THE CONTROL. ON THE WHOLE, MEN BENEFITED MORE THAN WOMEN FROM THE STUDY INTERVENTIONS. CONCLUSIONS: WE CONCLUDE THAT YOGA AND NATUROPATHY INTERVENTIONS IN ADDITION TO CHEMOTHERAPY SHOW IMPROVEMENT IN OVERALL FUNCTIONAL LIFE INDEX ALONG WITH IMPROVEMENT IN HAEMOGLOBIN IN PATIENTS WITH STAGES II AND III ADENOCARCINOMA OF COLON. 2020 5 459 41 CHANGES IN PAIN INTENSITY AND HEALTH RELATED QUALITY OF LIFE WITH IYENGAR YOGA IN NONSPECIFIC CHRONIC LOW BACK PAIN: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: NONSPECIFIC CHRONIC LOW BACK (NCLBP) PAIN IS PREVALENT AMONG ADULT POPULATION AND OFTEN LEADS TO FUNCTIONAL LIMITATIONS, PSYCHOLOGICAL SYMPTOMS, LOWER QUALITY OF LIFE (QOL), AND HIGHER HEALTHCARE COSTS. THE PURPOSE OF THIS STUDY WAS TO DETERMINE THE EFFICACY OF IYENGAR YOGA THERAPY ON PAIN INTENSITY AND HEALTH RELATED QUALITY OF LIFE (HRQOL) WITH NCLBP. AIM OF THE STUDY: TO COMPARE THE EFFECT OF IYENGAR YOGA THERAPY AND CONVENTIONAL EXERCISE THERAPY ON PAIN INTENSITY AND HRQOL IN NONSPECIFIC CHRONIC LOW BACK PAIN. MATERIALS AND METHODS: EXPERIMENTAL STUDY WITH RANDOM SAMPLING TECHNIQUE. SUBJECTS/INTERVENTION: SIXTY SUBJECTS WHO FULFILLED THE SELECTION CRITERIA WERE RANDOMLY ASSIGNED TO IYENGAR YOGA (YOGA GROUP, N = 30) AND CONTROL GROUP (EXERCISE GROUP, N = 30). PARTICIPANTS COMPLETED LOW BACK PAIN EVALUATION FORM AND HRQOL-4 QUESTIONNAIRE BEFORE THEIR INTERVENTION AND AGAIN 4 WEEKS AND 6 MONTH LATER. YOGA GROUP UNDERWENT 29 YOGIC POSTURES TRAINING AND EXERCISE GROUP HAD UNDERGONE GENERAL EXERCISE PROGRAM FOR 4 WEEKS. STATISTICS: REPEATED MEASURES ANALYSIS OF VARIANCE (ANOVA) WAS USED TO ANALYZE GROUP DIFFERENCES OVER TIME, WHILE CONTROLLING FOR BASELINE DIFFERENCES. RESULTS: PATIENTS IN BOTH GROUPS EXPERIENCED SIGNIFICANT REDUCTION IN PAIN AND IMPROVEMENT IN HRQOL. IN VISUAL ANALOGUE SCALE (VAS) YOGA GROUP SHOWED REDUCTION OF 72.81% (P = 0.001) AS COMPARED TO EXERCISE GROUP 42.50% (P = 0.001). IN HRQOL, YOGA GROUP SHOWED REDUCTION OF 86.99% (P = 0.001) AS COMPARED TO EXERCISE GROUP 67.66% (P = 0.001). CONCLUSION: THESE RESULTS SUGGEST THAT IYENGAR YOGA PROVIDES BETTER IMPROVEMENT IN PAIN REDUCTION AND IMPROVEMENT IN HRQOL IN NONSPECIFIC CHRONIC BACK PAIN THAN GENERAL EXERCISE. 2014 6 2896 32 [EFFECT OF YOGA ON CANCER RELATED FATIGUE IN BREAST CANCER PATIENTS WITH CHEMOTHERAPY]. OBJECTIVE: TO EVALUATE THE CONDITION OF CANCER-RELATED FATIGUE (CRF) IN BREAST CANCER PATIENTS WITH CHEMOTHERAPY AND TO EXPLORE THE EFFECT OF YOGA ON IT. METHODS: AFTER THE COMPLETION OF YOGA, 100 BREAST CANCER PATIENTS WITH CRF (CFS>0) WERE SELECTED AND WERE RANDOMLY DIVIDED INTO THE YOGA GROUP AND THE CONTROL GROUP (N=50). PATIENTS IN THE CONTROL GROUP ONLY RECEIVED ROUTINE CURE AND CARE WHILE PATIENTS IN THE YOGA GROUP RECEIVED EXTRA YOGA EXERCISE, LASTING FOR 4 MONTHS. CANCER FATIGUE SCALE (CFS) WAS EVALUATED IN THE 2ND, 4TH AND 6TH ROUND OF CHEMOTHERAPY. RESULTS: AT THE END, 82 CASES QUALIFIED FOR THE STUDY, 42 CASES FOR THE CONTROL GROUP AND 40 FOR THE YOGA GROUP. THE MEAN SCORE OF BODY FATIGUE WAS 12.67+/-3.46. THERE WAS NO SIGNIFICANT DIFFERENCE IN CRF BETWEEN THE YAGO GROUP AND THE CONTROL GROUP BEFORE THE YOGA INTERVENTION (P>0.05). AFTER THE 4TH ROUND OF CHEMOTHERAPY, THE MEAN SCORES OF CFS AND BODY FATIGUE IN THE YOGA GROUP WERE SIGNIFICANTLY LOWER THAN THAT IN THE CONTROL GROUP (P<0.05). AFTER THE 6TH ROUND OF CHEMOTHERAPY, THE MEAN SCORES OF CFS, BODY FATIGUE AND COGNITIVE FATIGUE IN THE YOGA GROUP WERE LOWER THAN THAT IN THE CONTROL GROUP (P<0.05). REPEATED ANALYSIS OF VARIANCE SHOWED THAT THE DIFFERENCE IN THE OVERALL FATIGUE, BODY FATIGUE AND COGNITIVE FATIGUE BETWEEN THE YOGA GROUP AND THE CONTROL GROUP WAS SIGNIFICANT (P<0.05); THE TIME INFLUENCE ON THE OVERALL FATIGUE, BODY FATIGUE AND EMOTIONAL FATIGUE WAS SIGNIFICANT DIFFERENCE BETWEEN THE 2 GROUPS (P<0.05); THERE WERE INTERACTIONS BETWEEN THE EFFECT OF YAGO AND TIME ON THE OVERALL FATIGUE, BODY FATIGUE AND COGNITIVE FATIGUE (P<0.05). CONCLUSION: THE BODY FATIGUE WAS MORE SERIOUS IN BREAST CANCER PATIENTS WITH CHEMOTHERAPY. YOGA INTERVENTION COULD SIGNIFICANTLY REDUCE BODY FATIGUE, COGNITIVE FATIGUE, THUS REDUCE THE OVERALL FATIGUE IN BREAST CANCER PATIENTS WITH CHEMOTHERAPY. 2014 7 2221 28 THE IMPACT OF LAUGHTER YOGA ON THE STRESS OF CANCER PATIENTS BEFORE CHEMOTHERAPY. BACKGROUND: CANCER IS USUALLY ACCOMPANIED BY CONSIDERABLE STRESS FOR THE SUFFERER, AND THE STRESS HAS DESTRUCTIVE EFFECTS ON CHEMOTHERAPY TREATMENT PROCESS. THEREFORE, THE CURRENT RESEARCH DEALS WITH THE EFFECT OF YOGA LAUGHTER ON THE CANCER PATIENTS' STRESS BEFORE CHEMOTHERAPY. METHODS: IN THIS RESEARCH, AS THE FIRST STEP, 37 CANCER SUFFERERS , WHO HAD BEEN HOSPITALIZED IN SHOHADA TAJRISH HOSPITAL (BEHNAM DANESHPOOR CHARITY ORGANIZATION) AND HAD THE REQUIREMENTS NECESSARY FOR BEING TAKEN AS RESEARCH SAMPLES, WERE SELECTED FOR DATA COLLECTION. THE MENTIONED PATIENTS WERE CLASSIFIED RANDOMLY IN EXPERIMENTAL AND CONTROL GROUPS. COLLECTED DATA WERE ANALYZED BY THE MULTI-VARIABLE COVARIANCE ANALYSIS TEST. RESULTS: THE RESULTS SHOW THERE IS A MEANINGFUL DIFFERENCE IN THE STRESS AVERAGE BEFORE AND AFTER INTERFERENCE IN THE TEST GROUP (P<0.05). CONCLUSION: LAUGHTER YOGA CAN DECREASE THE STRESS IN CANCER SUFFERERS BEFORE CHEMOTHERAPY. 2014 8 2173 27 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 9 2112 28 THE EFFECT OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN. BACKGROUND: IN RECENT DECADES, SEVERAL MEDICAL AND SCIENTIFIC STUDIES ON YOGA PROVED IT TO BE VERY USEFUL IN THE TREATMENT OF SOME DISEASES. THIS STUDY WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN LIVING IN ILAM, IRAN. METHODS: THIS STUDY IS A QUASI-EXPERIMENTAL STUDY WITH PRE-POST TEST. TO COLLECT DATA, THE QUESTIONNAIRE OF DASS-21 (DEPRESSION ANXIETY STRESS SCALE-21) WAS USED. FOR ELIGIBLE SAMPLES, HATHA YOGA EXERCISES AND TRAINING SESSIONS WERE HELD FOR 4 WEEKS (3 TIME/WEEKS; 60-70 MIN EACH) BY A SPECIALIST. DATA WERE ANALYZED USING SPSS VERSION 20. RESULTS: 52 WOMEN WITH A MEAN AGE OF 33.5 +/- 6.5 WERE INCLUDED FOR ANALYSIS. DEPRESSION, ANXIETY, AND STRESS DECREASED SIGNIFICANTLY IN WOMEN AFTER 12 SESSIONS OF REGULAR HATHA YOGA PRACTICE (P < 0.001). CONCLUSIONS: YOGA HAS AN EFFECTIVE ROLE IN REDUCING STRESS, ANXIETY, AND DEPRESSION. THUS, IT CAN BE USED AS COMPLEMENTARY MEDICINE. 2018 10 2103 31 THE EFFECT OF YOGA ON FUNCTIONAL RECOVERY LEVEL IN SCHIZOPHRENIC PATIENTS. PURPOSE: THE OBJECTIVE OF THIS STUDY IS TO DETERMINE THE EFFECT OF YOGA ON FUNCTIONAL RECOVERY LEVEL IN SCHIZOPHRENIC PATIENTS. MATERIALS AND METHODS: THE STUDY WAS CONDUCTED IN QUASI-EXPERIMENTAL DESIGN WITH PRETEST-POSTTEST CONTROL GROUP. THE POPULATION OF THE STUDY CONSISTED OF SCHIZOPHRENIC PATIENTS WITH REGISTERED IN MALATYA AND ELAZIG COMMUNITY MENTAL HEALTH CENTERS AND REGULARLY GOING TO THESE CENTERS. THE SAMPLE GROUP OF THE STUDY CONSISTED OF TOTALLY 100 PATIENTS INCLUDING 50 PATIENTS IN THE EXPERIMENTAL GROUP AND 50 PATIENTS IN THE CONTROL GROUP WHO WERE SPECIFIED THROUGH POWER ANALYSIS AND CHOSEN BY USING RANDOM SAMPLING METHOD FROM THIS POPULATION. THE DATA WERE COLLECTED BETWEEN APRIL 2015 AND AUGUST 2015. 'PATIENT DESCRIPTION FORM' AND 'FROGS' WERE USED TO COLLECT THE DATA. YOGA WAS APPLIED TO PATIENTS IN THE EXPERIMENTAL GROUP. ANY INTERVENTION WAS NOT MADE TO PATIENTS IN THE CONTROL GROUP. PERCENTAGE DISTRIBUTION, ARITHMETIC MEAN, STANDARD DEVIATION, CHI-SQUARE, INDEPENDENT SAMPLES T TEST, AND PAIRED T TEST WERE USED TO ASSESS THE DATA. RESULTS: PATIENTS IN THE CONTROL AND EXPERIMENTAL GROUP PRETEST SUBSCALE AND THE TOTAL MEANS SCORES OF FROGS WAS FOUND TO BE LOW. IN THE POSTTEST SUBSCALE AND TOTAL MEANS SCORES OF FROGS IN THE EXPERIMENTAL GROUP WERE HIGHER THAN IN THE CONTROL GROUP AND THE DIFFERENCES BETWEEN THEM WERE FOUND TO BE STATISTICALLY SIGNIFICANT (P<0.05). IN THE EXPERIMENTAL GROUP PRETEST AND POSTTEST SUBSCALE AND TOTAL MEANS SCORES OF FR0GS WAS DETERMINED TO BE STATISTICALLY SIGNIFICANT (P<0.05). CONCLUSION: YOGA THAT APPLIED TO SCHIZOPHRENIC PATIENTS IT WAS DETERMINED TO INCREASED THE LEVEL OF FUNCTIONAL RECOVERY. IT CAN BE SUGGESTED THAT YOGA SHOULD BE USED AS AN COMPLEMENTARY METHOD IN NURSING PRACTISE IN ORDER TO INCREASE THE EFFECTIVENESS OF THE TREATMENT. 2016 11 2461 34 YOGA AS A NOVEL ADJUVANT THERAPY FOR PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES. CONTEXT: RECENT STUDIES HAVE DEMONSTRATED THAT PHYSICAL ACTIVITY IS WELL TOLERATED BY PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) AND CAN HAVE ADDITIONAL BENEFITS AS AN ADJUVANT THERAPY TO PHARMACOLOGIC AGENTS, ESPECIALLY IF STARTED EARLY. TO DATE, NO STUDIES HAVE EXAMINED THE EFFECTS OF YOGA ON PATIENTS WITH IIMS. AIMS: THE AIM OF THIS STUDY WAS TO EVALUATE THE EFFECTS OF YOGA ON SELF-REPORTED DIFFICULTY IN PERFORMING ACTIVITIES OF DAILY LIVING (ADL) AND MUSCLE STRENGTH IN PATIENTS WITH MILD-TO-MODERATE IIMS. SUBJECTS AND METHODS: A LONGITUDINAL COHORT STUDY IN WHICH PARTICIPANTS WERE ASSESSED USING THE MYOSITIS ACTIVITIES PROFILE (MAP) AND MANUAL MUSCLE TESTING (MMT) BEFORE AND AFTER THE COMPLETION OF AN 8-WEEK INSTRUCTOR-GUIDED YOGA COURSE WAS PERFORMED. STATISTICAL ANALYSIS USED: WILCOXON SIGNED-RANKED TEST WAS PERFORMED FOR STATISTICAL ANALYSIS. RESULTS: THE AVERAGE POSTTREATMENT MAP SCORES OF SIX PARTICIPANTS DEMONSTRATED AN INCREASE OF 2.51 POINTS, WHILE THE AVERAGE MMT SCORE OF FOUR PARTICIPANTS DEMONSTRATED AN INCREASE OF 11 POINTS. CONCLUSIONS: THIS STUDY IS THE FIRST STUDY TO DATE TO EXAMINE THE EFFECT OF YOGA AS AN ADJUVANT COMPLEMENTARY THERAPY FOR PATIENTS WITH IIM. CONTINUED RESEARCH SHOULD BE DONE ON THE EFFECT OF YOGA AS AN ADJUVANT THERAPY, FOR IN ADDITION TO INCREASE IN MUSCLE STRENGTH AND ABILITY TO PERFORM ADL, YOGA MAY OFFER POTENTIAL IMPROVEMENTS IN MOOD, MENTAL HEALTH, AND SLEEP. 2021 12 1046 33 EFFECTS OF YOGA ON ANXIETY AND DEPRESSION FOR HIGH RISK MOTHERS ON HOSPITAL BEDREST. BACKGROUND: AND PURPOSE: IN RECENT YEARS, YOGA PRACTITIONERS HAVE JOINED FORCES WITH MEDICAL PROGRAMS TO APPROACH PATIENTS' WELL-BEING HOLISTICALLY. THIS STUDY IS A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFECTS OF A SPECIALIZED ADAPTED YOGA PROGRAM ON ANXIETY AND DEPRESSION FOR HIGH-RISK EXPECTANT MOTHERS ON BEDREST IN A HOSPITAL SETTING. MATERIALS AND METHODS: SEVENTY-NINE PREGNANT SUBJECTS ON PHYSICIAN ORDERED HOSPITALIZED BEDREST WERE RANDOMIZED INTO TWO GROUPS: RECEIVING BIWEEKLY YOGA SESSIONS (INTERVENTION GROUP) OR RECEIVING NO YOGA (CONTROL GROUP). DATA COLLECTION TOOL WAS THE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) TO ASSESS OUTCOMES AFTER DELIVERY. RESULTS: YOGA, EVEN AS LITTLE AS THREE SESSIONS, SHOWED SIGNIFICANT IMPACT IN REDUCING ANXIETY AND DEPRESSION HIGH-RISK PREGNANT WOMEN ON HOSPITALIZED BEDREST. PERCEIVED ANXIETY AND DEPRESSION OVERALL SCORES WERE LOWER IN THE INTERVENTION GROUP THAN IN THE CONTROL GROUP (P < 0.001). CONCLUSION: RESULTS DEMONSTRATED THAT YOGA IS AN EFFECTIVE INTERVENTION TO DECREASE ANXIETY AND DEPRESSION IN HIGH-RISK ANTEPARTUM WOMEN ON HOSPITALIZED BEDREST. 2020 13 1081 35 EFFECTS OF YOGA ON SEXUAL FUNCTION IN WOMEN WITH METABOLIC SYNDROME: A RANDOMIZED CONTROLLED TRIAL. INTRODUCTION: FEMALE SEXUAL DYSFUNCTION IS AN IMPORTANT PUBLIC HEALTH ISSUE; IT HAS A HIGH GLOBAL PREVALENCE, BUT NO EFFECTIVE AND SAFE TREATMENT OPTIONS. THE PREVALENCE OF SEXUAL DYSFUNCTION IS HIGHER IN WOMEN WITH METABOLIC SYNDROME THAN IN THE GENERAL POPULATION. AIM: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFICACY OF YOGA AS A TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME. METHODS: IN THIS RANDOMIZED, CONTROLLED STUDY, 41 WOMEN WITH METABOLIC SYNDROME (AGE 30-60 YEARS) WERE ASSIGNED TO A 12-WEEK YOGA EXERCISE GROUP (N=20) OR A WAIT-LISTED CONTROL GROUP (N=21). MAIN OUTCOME MEASURES: PRIMARY END POINTS WERE CHANGES IN TOTAL AND INDIVIDUAL DOMAIN SCORES ON THE FEMALE SEXUAL FUNCTION INDEX. RESULTS: THE 12-WEEK YOGA INTERVENTION RESULTED IN SIGNIFICANT IMPROVEMENT IN AROUSAL (0.74+/-1.18 VS. 0.16+/-0.82, RESPECTIVELY; P=0.042) AND LUBRICATION (0.72+/-1.12 VS. 0.06+/-0.87, RESPECTIVELY; P=0.008) COMPARED WITH THE CONTROL GROUP. SYSTOLIC BLOOD PRESSURE SHOWED SIGNIFICANTLY GREATER IMPROVEMENT IN THE YOGA GROUP THAN IN THE CONTROL GROUP AT THE 12-WEEK FOLLOW UP (-3.5+/-13.7 VS. 2.0+/-14.7, RESPECTIVELY; P=0.040). CONCLUSION: THESE FINDINGS SUGGEST THAT YOGA MAY BE AN EFFECTIVE TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME AS WELL AS FOR METABOLIC RISK FACTORS. 2013 14 1833 27 PSYCHOLOGICAL WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS: A PILOT STUDY. SCHIZOPHRENIA IS A SERIOUS PSYCHIATRIC DISORDER CHARACTERIZED BY POSITIVE SYMPTOMS, NEGATIVE SYMPTOMS AND NEUROCOGNITIVE DEFICITS. THE AIM OF THIS STUDY WAS TO ESTIMATE RELATIONSHIPS BETWEEN WELLNESS, YOGA AND QUALITY OF LIFE IN PATIENTS AFFECTED BY SCHIZOPHRENIA SPECTRUM DISORDERS. PARTICIPANTS WERE 30 PATIENTS WITH A DIAGNOSIS OF SCHIZOPHRENIA IN CARE AT THE REHABILITATIVE PSYCHIATRY AND RESEARCH VILLA CHIARA CLINIC IN MASCALUCIA (CATANIA, ITALY), AFTER THAT RANDOMLY ASSIGNED TO TWO GROUPS. THE FIRST GROUP FOLLOWED THE EXPERIMENTAL TREATMENT WITH SETS OF YOGA EXERCISES CONDUCTED BY A YOGA TRAINER AND A PSYCHIATRIST OR A CLINICAL PSYCHOLOGIST EXPERT IN YOGA, WHILE A SECOND CONTROL GROUP WAS TREATED WITH USUAL CARE. THE RESULTS REVEALED A SIGNIFICANT DIFFERENCE, BEFORE AND AFTER TREATMENT, BETWEEN THE EXPERIMENTAL GROUP AND THE CONTROL GROUP IN QUALITY OF LIFE. 2019 15 2073 39 THE EFFECT OF A STRETCH AND STRENGTH-BASED YOGA EXERCISE PROGRAM ON PATIENTS WITH NEUROPATHIC PAIN DUE TO LUMBAR DISC HERNIATION. STUDY DESIGN: RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TO INVESTIGATE THE EFFECT OF A STRETCH AND STRENGTHBASED YOGA EXERCISE PROGRAM ON NEUROPATHIC PAIN DUE TO LDH. SUMMARY OF BACKGROUND DATA: LDH WITH NEUROPATHIC PAIN INFLUENCES TREATMENT OUTCOMES NEGATIVELY. MOST YOGA POSES INCLUDE THE PARAMETERS OF SPINAL TRAINING AND HELP REDUCE PAIN AND DISABILITY IN PATIENTS WITH LOW BACK INJURIES. WE HYPOTHESIZED THAT YOGA POSITIVELY AFFECTS BOTH LDH AND NEUROPATHIC PAIN BY INCREASING MOBILIZATION, CORE MUSCLE STRENGTH, AND SPINAL AND HAMSTRING FLEXIBILITY. METHODS: IN TOTAL, 48 PATIENTS WITH NEUROPATHIC PAIN DUE TO LDH WERE RANDOMLY ASSIGNED TO A CONTROL GROUP AND A YOGA GROUP. ALL PATIENTS UNDERWENT A PATIENT EDUCATION PROGRAM. IN ADDITION, THE SELECTED YOGA EXERCISE WAS TAUGHT AND PERFORMED TO THE YOGA GROUP FOR ONE HOUR TWICE WEEKLY FOR 12 WEEKS. NEUROPATHIC PAIN (DOULEUR NEUROPATHIQUE 4 FOR DIAGNOSIS; LEEDS ASSESSMENT OF NEUROPATHIC SYMPTOMS AND SIGNS FOR SEVERITY), LOW BACK PAIN (THE SHORT-FORM OF MCGILL PAIN QUESTIONNAIRE), DISABILITY (OSWESTRY DISABILITY INDEX), AND FUNCTION (MODIFIED SCHOBER AND PASSIVE KNEE EXTENSION TEST) WERE MEASURED BLIND BEFORE AND AT THE ONE-, THREE-, AND SIX-MONTH FOLLOW-UPS. THE PATIENT GLOBAL ASSESSMENT WAS APPLIED AT THE SIX-MONTH FOLLOWUP. THE INTENTION-TO-TREAT ANALYSIS WAS PERFORMED IN THIS STUDY. RESULTS: THE INTENTION-TO-TREAT ANALYSIS SHOWED A STATISTICALLY SIGNIFICANT DIFFERENCE IN NEUROPATHIC PAIN, PATIENT GLOBAL ASSESS MENT, LOW BACK PAIN, DISABILITY, AND FUNCTION IN FAVOR OF THE YOGA GROUP AT POST-TREATMENT. THE BETWEEN-GROUP EFFECT SIZES WERE MODERATE AT SIX-MONTHS FOLLOW-UP. CONCLUSION: IT WAS DETERMINED THAT THE SELECTED STRETCH AND STRENGTH-BASED YOGA EXERCISE COULD BE A PROMISING TREATMENT OPTION FOR NEUROPATHIC PAIN DUE TO LDH. LEVEL OF EVIDENCE: 2. 2022 16 1085 34 EFFECTS OF YOGA ON STRESS, FATIGUE, MUSCULOSKELETAL PAIN, AND THE QUALITY OF LIFE AMONG EMPLOYEES OF DIAMOND INDUSTRY: A NEW APPROACH IN EMPLOYEE WELLNESS. BACKGROUND: DIAMOND INDUSTRY EMPLOYEES OFTEN EXPERIENCE MUSCULOSKELETAL PAIN, FATIGUE, AND STRESS, CONTRIBUTING TO A LOW QUALITY OF LIFE (QOL). YOGA IS AN ANCIENT DISCIPLINE OF MIND-BODY PRACTICE YOGA HAS NUMEROUS HEALTH BENEFITS. OBJECTIVE: THIS STUDY INVESTIGATED THE EFFICACY OF WORKPLACE YOGA IN IMPROVING STRESS, MUSCULOSKELETAL PAIN, FATIGUE, AND QOL AMONG EMPLOYEES OF THE DIAMOND INDUSTRY. METHODS: ONE-HUNDRED SIXTY-SIX EMPLOYEES OF THE DIAMOND INDUSTRY BETWEEN THE AGES OF 20 AND 60 PARTICIPATED IN THE STUDY. PARTICIPANTS WERE ASSIGNED TO EITHER YOGA (N = 84) OR WAITLIST (N = 82) GROUPS. THE YOGA GROUP RECEIVED ONE HOUR OF YOGA, FOUR DAYS A WEEK FOR THREE CONSECUTIVE MONTHS. PARTICIPANTS IN THE WAITLIST GROUP FOLLOWED THEIR DAILY ROUTINES. MUSCULOSKELETAL PAIN, FATIGUE, STRESS, AND QOL WERE ASSESSED AT BASELINE AND AFTER THREE MONTHS. RESULTS: ONE-HUNDRED FIFTY-FIVE EMPLOYEES COMPLETED THE STUDY. THE YOGA GROUP SHOWED SIGNIFICANT (P < 0.05) IMPROVEMENT IN PAIN, PERCEIVED STRESS, FATIGUE, AND QOL DOMAINS AFTER THREE MONTHS COMPARED TO BASELINE. THE WAITLIST GROUP SHOWED NO SIGNIFICANT IMPROVEMENT IN ANY OF THE MEASURES. IN THE POST SCORES COMPARISON BETWEEN THE GROUPS REVEALED A SIGNIFICANT DIFFERENCE BETWEEN THE GROUPS. CONCLUSION: WORKPLACE YOGA FOUND TO BE A USEFUL, COST-EFFECTIVE AND FEASIBLE INTERVENTION IN IMPROVING STRESS, MUSCULOSKELETAL PAIN, FATIGUES AND QUALITY OF LIFE AMONG EMPLOYEES OF THE DIAMOND INDUSTRY. YOGA MAY BE IMPLEMENTED IN THE WORKPLACE AS A WELLNESS PROGRAM AT THE WORKPLACE. 2021 17 748 33 EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. OBJECTIVE: THE PRESENT STUDY INVESTIGATES THE EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. DESIGN: THE PROSPECTIVE OBSERVATIONAL COHORT STUDY ENROLLED TWO STUDY GROUPS: THOSE RECEIVING TREATMENT FROM THE INTERNATIONAL SAHAJA YOGA RESEARCH AND HEALTH CENTER (MEDITATION GROUP) AND THOSE RECEIVING TREATMENT FROM THE MAHATMA GANDHI MISSION HOSPITAL (CONTROL GROUP). RESEARCHERS MEASURED QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE BEFORE AND AFTER TREATMENT. RESULTS: SIXTY-SEVEN (67) PARTICIPANTS IN THE MEDITATION GROUP AND 62 PARTICIPANTS IN THE CONTROL GROUP COMPLETED THE STUDY. THE TWO GROUPS WERE COMPARABLE IN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS. AT BASELINE, THE MEDITATION GROUP HAD HIGHER QUALITY OF LIFE (P<0.001) THAN CONTROLS BUT SIMILAR ANXIETY LEVEL (P=0.74) TO CONTROLS. WITHIN-GROUP PRE- VERSUS POST-TREATMENT COMPARISONS SHOWED SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE IN THE MEDITATION GROUP (P<0.001), WHILE IN CONTROLS, QUALITY OF LIFE DETERIORATED AND THERE WAS NO IMPROVEMENT IN BLOOD PRESSURE. THE IMPROVEMENT IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL WAS GREATER IN THE MEDITATION GROUP. THE BENEFICIAL EFFECT OF MEDITATION REMAINED SIGNIFICANT AFTER ADJUSTING FOR CONFOUNDERS. CONCLUSIONS: MEDITATION TREATMENT WAS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL. 2012 18 983 36 EFFECTS OF HATA YOGA ON KNEE OSTEOARTHRITIS. BACKGROUND: THE PURPOSE OF THIS RESEARCH WAS TO STUDY THE EFFECTS OF 8 WEEKS OF HATA YOGA EXERCISES ON WOMEN WITH KNEE OSTEOARTHRITIS. STUDIES ABOUT EFFECTS OF YOGA ON DIFFERENT CHRONIC DISEASES SHOW THAT THESE EXERCISES HAVE POSITIVE EFFECTS ON CHRONIC DISEASES. AS KNEE OSTEOARTHRITIS IS VERY COMMON AMONG MIDDLE AGE WOMEN WE DECIDED TO MEASURE EFFECTIVENESS OF THESE EXERCISES ON KNEE OSTEOARTHRITIS. METHODS: SAMPLE INCLUDED 30 WOMEN WITH KNEE OSTEOARTHRITIS WHO VOLUNTARILY PARTICIPATED IN THIS SEMI-EXPERIMENTAL STUDY AND WERE DIVIDED INTO A CONTROL GROUP (15) AND A YOGA GROUP (15). THE YOGA GROUP RECEIVED 60 MINUTES SESSIONS OF HATA YOGA, 3 TIMES A WEEK AND FOR 8 WEEKS. PAIN, SYMPTOMS, DAILY ACTIVITIES, SPORTS AND SPARE-TIME ACTIVITIES, AND QUALITY OF LIFE WERE RESPECTIVELY MEASURED BY VISUAL ANALOG SCALE (VAS) AND KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCALE (KOOS) QUESTIONNAIRE. THE ANALYSIS OF VARIANCE (ANOVA) METHOD FOR REPETITIVE DATA WAS USED TO ANALYZE THE RESULTS (P = 0.05). RESULTS: FINDINGS SHOWED THAT PAIN AND SYMPTOMS WERE SIGNIFICANTLY DECREASED AND SCORES OF DAILY ACTIVITIES, SPORTS, SPARE-TIME ACTIVITIES, AND QUALITY OF LIFE WERE SIGNIFICANTLY INCREASED IN THE YOGA GROUP. CONCLUSIONS: IT SEEMS THAT YOGA CAN BE USED AS A CONSERVATIVE TREATMENT BESIDES USUAL TREATMENTS AND MEDICATIONS TO IMPROVE THE CONDITION OF PEOPLE WITH OSTEOARTHRITIS. 2013 19 2464 45 YOGA AS A THERAPEUTIC INTERVENTION IN THE MANAGEMENT OF DYSFUNCTIONAL UTERINE BLEEDING: A CONTROLLED PILOT STUDY. BACKGROUND: DYSFUNCTIONAL UTERINE BLEEDING (DUB) IS ONE OF THE MOST COMMON GYNECOLOGICAL DISORDERS ENCOUNTERED IN WOMEN DURING THE REPRODUCTIVE AGE. YOGA THERAPY HAS SHOWN PROMISING BENEFITS IN SEVERAL GYNECOLOGICAL DISORDERS. METHODS: THIRTY WOMEN BETWEEN THE AGES OF 20 AND 40 YEARS WITH PRIMARY DUB WERE RANDOMLY ASSIGNED TO A YOGA (N = 15) AND A WAITLIST CONTROL GROUP (N = 15). PARTICIPANTS IN THE YOGA GROUP RECEIVED A 3-MONTH YOGA MODULE AND WERE ASSESSED FOR HEMOGLOBIN VALUES, ENDOMETRIAL THICKNESS (ET), PICTORIAL BLOOD LOSS ASSESSMENT CHART (PBAC), STATE-TRAIT ANXIETY INVENTORY, PERCEIVED STRESS SCALE, AND PITTSBURGH SLEEP QUALITY INDEX (PSQI) BEFORE AND AFTER A 3-MONTH FOLLOW-UP PERIOD. RESULTS: AT THE END OF 3 MONTHS OF INTERVENTION, THE YOGA GROUP, UNLIKE THE CONTROL GROUP, REPORTED A SIGNIFICANT REDUCTION IN THE ANXIETY SCORES (P < 0.05) AND PERCEIVED STRESS (P < 0.05). THE PSQI SCORES INDICATED A REDUCTION IN SLEEP DISTURBANCES (P < 0.001) AND THE NEED FOR SLEEP MEDICATIONS (P < 0.01) AND HIGHER GLOBAL SCORES (P < 0.001). HOWEVER, THERE WERE NO CHANGES IN PBAC AND ET IN BOTH THE GROUPS. CONCLUSION: THE RESULTS INDICATE THAT YOGA THERAPY POSITIVELY IMPACTS THE OUTCOME OF DUB BY REDUCING THE PERCEIVED STRESS AND STATE ANXIETY AND IMPROVING THE QUALITY OF SLEEP. THIS WARRANTS LARGER CLINICAL TRIALS TO VALIDATE THE FINDINGS OF THIS PILOT STUDY. 2018 20 819 31 EFFECT OF YOGA ON DEPRESSION IN HYPOTHYROIDISM: A PILOT STUDY. BACKGROUND: THE PREVALENCE OF HYPOTHYROIDISM AMONG INDIAN WOMEN IS 15.8%. DEPRESSION IS FREQUENTLY REPORTED IN HYPOTHYROIDISM. YOGA IS AN EFFECTIVE INTERVENTION FOR DEPRESSION. HOWEVER, THE INFLUENCE OF YOGA ON DEPRESSION IN PATIENTS WITH HYPOTHYROIDISM HAS NOT BEEN STUDIED. AIM: THE PRESENT STUDY INVESTIGATED THE EFFECT OF A 3-MONTH INTEGRATED YOGA INTERVENTION (3-IY) ON DEPRESSION, LIPID INDICES, AND SERUM THYROID-STIMULATING HORMONE (STSH) LEVELS AMONG FEMALE PATIENTS HAVING HYPOTHYROIDISM, AND MILD-TO-MODERATE DEPRESSION. METHOD: THE PRESENT SINGLE-ARM PRE-POST DESIGN STUDY WAS CONDUCTED IN THIRTY-EIGHT WOMEN (AVERAGE AGE 34.2 +/- 4.7 YEARS). PARTICIPANTS RECEIVED A 3-IY COMPRISING ASANAS, PRANAYAMA, AND RELAXATION TECHNIQUES FOR 60 MIN DAILY (5 DAYS A WEEK). DEPRESSION, STSH, LIPID PROFILE INDICES, BODY MASS INDEX (BMI), FATIGUE, ANXIETY, AND STRESS WERE ASSESSED AT BASELINE AND AFTER 12 WEEKS. THYROID MEDICATION WAS KEPT CONSTANT DURING THE STUDY PERIOD. DATA WERE ANALYSED USING R STUDIO SOFTWARE. RESULT: A SIGNIFICANT (P < 0.05) REDUCTION IN DEPRESSION (58%), STSH (37%), BMI (6%), FATIGUE (64%), ANXIETY (57%), LIPID PROFILE INDICES (HLD INCREASED SIGNIFICANTY), AND STRESS (55%) LEVELS WAS OBSERVED AFTER 3 MONTHS, COMPARED WITH THE CORRESPONDING BASELINE LEVELS. CONCLUSION: THE 3-IY IS USEFUL FOR REDUCING DEPRESSION, DYSLIPIDEMIA, AND STSH IN WOMEN WITH HYPOTHYROIDISM AND DEPRESSION. FURTHER STUDIES WITH A LARGER SAMPLE SIZE AND A ROBUST RESEARCH DESIGN USING OBJECTIVE VARIABLES MUST BE CONDUCTED TO STRENGTHEN THE STUDY FINDINGS. 2021